NAUTILUS BIOTECHNOLOGY

nautilus-biotechnology-logo

Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expe... rtise, including protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.

#SimilarOrganizations #People #Financial #Event #Website #More

NAUTILUS BIOTECHNOLOGY

Social Links:

Industry:
Biotechnology Health Care Life Science Pharmaceutical

Founded:
2016-01-01

Address:
San Carlos, California, United States

Country:
United States

Website Url:
http://www.nautilus.bio

Total Employee:
101+

Status:
Active

Contact:
+1 206 333 2001

Email Addresses:
info@nautilus.bio

Total Funding:
303.2 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

imbria-pharmaceuticals-logo

Imbria Pharmaceuticals

Imbria Pharmaceuticals is a biotechnology company with locations in San Diego, CA, and Boston, MA.

q-state-biosciences-logo

Q-State Biosciences

Q-State has developed world-leading technologies and proprietary approaches for probing rare and genetic CNS conditions.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

lee-hartwell_image

Lee Hartwell Scientific Advisory Board Member @ Nautilus Biotechnology
Advisor

noosheen-hashemi_image

Noosheen Hashemi Investor & Advisor @ Nautilus Biotechnology
Advisor
2016-10-01

Current Employees Featured

sujal-patel_image

Sujal Patel
Sujal Patel Founder, CEO @ Nautilus Biotechnology
Founder, CEO
2016-12-01

nick-nelson_image

Nick Nelson
Nick Nelson SVP & CBO @ Nautilus Biotechnology
SVP & CBO

matthew-murphy_image

Matthew Murphy
Matthew Murphy General Counsel @ Nautilus Biotechnology
General Counsel
2021-04-01

ross-hartley_image

Ross Hartley
Ross Hartley Software Engineer @ Nautilus Biotechnology
Software Engineer

john-murphy_image

John Murphy
John Murphy Sr. Director Global Intellectual Property @ Nautilus Biotechnology
Sr. Director Global Intellectual Property
2020-12-01

subra-sankar_image

Subra Sankar
Subra Sankar SVP Product Development @ Nautilus Biotechnology
SVP Product Development
2021-01-01

parag-mallick_image

Parag Mallick
Parag Mallick Founder, Chief Scientist @ Nautilus Biotechnology
Founder, Chief Scientist
2016-12-01

mary-godwin_image

Mary Godwin
Mary Godwin Vice President Operations @ Nautilus Biotechnology
Vice President Operations
2020-01-01

Founder


parag-mallick_image

Parag Mallick

sujal-patel_image

Sujal Patel

Stock Details


Company's stock symbol is NASDAQ:NAUT

Investors List

ally-bridge-group_image

Ally Bridge Group

Ally Bridge Group investment in Post-IPO Equity - Nautilus Biotechnology

andreessen-horowitz_image

Andreessen Horowitz

Andreessen Horowitz investment in Post-IPO Equity - Nautilus Biotechnology

alyeska-investment-group_image

Alyeska Investment Group

Alyeska Investment Group investment in Post-IPO Equity - Nautilus Biotechnology

casdin-capital_image

Casdin Capital

Casdin Capital investment in Post-IPO Equity - Nautilus Biotechnology

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Post-IPO Equity - Nautilus Biotechnology

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - Nautilus Biotechnology

madrona-venture-group_image

Madrona Venture Group

Madrona Venture Group investment in Post-IPO Equity - Nautilus Biotechnology

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Equity - Nautilus Biotechnology

franklin-templeton-investments_image

Franklin Templeton Investments

Franklin Templeton Investments investment in Post-IPO Equity - Nautilus Biotechnology

vulcan-capital_image

Vulcan Capital

Vulcan Capital investment in Post-IPO Equity - Nautilus Biotechnology

Official Site Inspections

http://www.nautilus.bio Semrush global rank: 2.3 M Semrush visits lastest month: 8.18 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Nautilus Biotechnology"

Company ~ Nautilus Biotechnology

Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome.See details»

Nautilus Biotechnology - Crunchbase Company Profile …

Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome.See details»

Investor Relations | Nautilus Biotechnology Inc.

The Investor Relations website contains information about Nautilus Biotechnology Inc.'s business for stockholders, potential investors, and financial analysts.See details»

Nautilus Biotechnology (NAUT) Company Profile & Description

5 days ago Company profile for Nautilus Biotechnology, Inc. (NAUT) stock, with a description, list of executives, contact details and other key facts.See details»

Nautilus Biotechnology Joins Human Proteome Organization

Sep 1, 2022 Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine.See details»

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year …

SEATTLE, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today …See details»

Nautilus Biotechnology: Contact Details, Revenue, Funding, …

Nautilus Biotechnology is a Seattle-based company that is developing a high-throughput, high-resolution platform to analyze and decode the human genome. The company’s mission is to …See details»

Nautilus Biotechnology - VentureRadar

"Nautilus Biotechnology will ignite a transformation in biomedical research by delivering a high-throughput, low-cost platform for analyzing and quantifying the human proteome. Our first …See details»

Nautilus Biotechnology Expands Executive Team

Seattle, WA and San Carlos, CA, January 5, 2021 Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for quantifying the human proteome, today announced …See details»

Nautilus Biotechnology Co-founder and Chief Scientist Parag

Nov 30, 2023 Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics AwardSee details»

Nautilus Biotechnology, Inc. (NAUT) - Yahoo Finance

See the company profile for Nautilus Biotechnology, Inc. (NAUT) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»

Nautilus Biotechnology - LifeScienceHistory.com

Nautilus Biotechnology is a biomedical research company delivering a high-throughput, low-cost platform for analyzing quantifying the human proteome.See details»

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year …

Feb 23, 2023 Nautilus will host a conference call to discuss the fourth quarter and fiscal year 2022 financial results, business developments and outlook before market open on Thursday, …See details»

Nautilus at US HUPO 2025 – Bringing the proteome into focus …

Mar 6, 2025 At US HUPO 2025 in Philadelphia, we shared novel data generated by the Nautilus TM Proteome Analysis P latform and focused on how that data can be applied to revolutionize …See details»

Nautilus Biotechnology - ContactOut

Nautilus Biotechnology | 2,962 followers on LinkedIn. Delivering on the Promise of the Human Proteome | Born from the founders’ recognition that their diverse but complementary skills and …See details»

Nautilus Biotechnology - Work in biotech

Nautilus Biotechnology is unlocking the proteome to enable fundamental advances across human health and medicine. There is a wealth of information about human biology that is held within …See details»

Nautilus Biotechnology - Craft

Nautilus Biotechnology is a company that develops a platform for analyzing and quantifying the human proteome. It offers protein library preparation, decoding and quantification, and …See details»

Nautilus Biotechnology Company Overview, Contact Details

Jun 10, 2021 Learn more about Nautilus Biotechnology's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

Nautilus Biosciences - Crunchbase Company Profile & Funding

Nautilus Biosciences is a Canadian biotechnology company focused on the discovery and development of marine-derived natural products with applications in human and animal health …See details»

Establishing Canada’s first large-scale bioinnovation centre

Mar 20, 2025 Building a world-class facility for biomanufacturing, clean tech Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth – Cole Harbour, announced a …See details»

linkstock.net © 2022. All rights reserved